Slider
  • For Patients and their Families

    Here you will find useful information about clinic, our doctors, booking an appointment…

    Read more

     

  • For Health Professionals

    Find out useful information about our doctors, case studies….

    Read more

  • Announcements
    • Sydney Retina and the Sydney Institute of Vision Science are actively involved in clinical trials which facilitate not only new drugs but existing drugs becoming available for a wider range of indications.¬†Existing drugs approved for new indications means that drugs that were previously not accessible can now be used and are now PBS subsidised.

       

       

       

       

       

      Read more
    • An orange a day keeps the macular degeneration away.

      http://www.abc.net.au/news/2018-07-18/oranges-may-reduce-macular-degeneration-risk/10002722

       

       

       

       

       

      Sydney Retina is committed to ensuring that your privacy and medical records are secure.

      Read more
    MORE FROM RESOURCE CENTRE
    • Scientific Journal Publications

      Publications

      2018 Chang A, Kawasaki R, – Asia Pacific-Technology and Trend Survey. APJO (In Press) Spooner K, Bahrami B,

      Read more
    • Abstracts

      Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration.

      Acta Ophthalmol. 2014 Dec;92(8):713-23. doi: 10.1111/aos.12463. Epub 2014 Jun 12. Broadhead GK 1 , Hong T, Chang AA.

      Read more
    • Abstracts

      Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes.

      Graefes Arch Clin Exp Ophthalmol. 2015 Aug;253(8):1217-25. doi: 10.1007/s00417-014-2799-8. Epub 2014 Sep 10. Zhu M 1 , Chew

      Read more
    OUR AFFILIATES